Correlation Between Vaccinex and Enliven Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Enliven Therapeutics, you can compare the effects of market volatilities on Vaccinex and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Enliven Therapeutics.

Diversification Opportunities for Vaccinex and Enliven Therapeutics

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vaccinex and Enliven is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Vaccinex i.e., Vaccinex and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between Vaccinex and Enliven Therapeutics

Given the investment horizon of 90 days Vaccinex is expected to under-perform the Enliven Therapeutics. In addition to that, Vaccinex is 1.43 times more volatile than Enliven Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest  1,126  in Enliven Therapeutics on August 26, 2024 and sell it today you would earn a total of  1,328  from holding Enliven Therapeutics or generate 117.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vaccinex  vs.  Enliven Therapeutics

 Performance 
       Timeline  
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Enliven Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Vaccinex and Enliven Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaccinex and Enliven Therapeutics

The main advantage of trading using opposite Vaccinex and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.
The idea behind Vaccinex and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios